Miyai K, Richardson A L, Mayr W, Javitt N B
Lab Invest. 1977 Mar;36(3):249-58.
Cholestasis or choleresis was induced in the rat by intravenous infusion (0.05 to 0.2 mumole per minute per 100 grams of body weight) of sodium taurolithocholate, 3beta-hydroxy-5-cholenoate, taurocholate, and dehydrocholate either singly or in combination after or without cannulation of the common bile duct. Bile flow was monitored and ultrastructural changes were examined by scanning and transmission electron microscopy up to 3 hours after bile salt administration. Taurolithocholate induced acute cholestasis and ultrastructural alterations consisting primarily of dilation of bile canaliculi, loss of canalicular microvilli, and lamellar transformation of the canalicular membrane. Occasionally, crystalline precipitates were present within the canalicular lumen and in the pericanalicular region of hepatocytes. 3beta-Hydroxy-5-cholenoate caused similar but less severe ultrastructural changes than those induced by taurolithocholate. Dehydrocholate had a greater choleretic effect than taurocholate, but neither induced noteworthy ultrastructural change. When infused simultaneously with taurolithocholate, taurocholate reversed cholestasis and largely prevented development of the ultrastructural changes induced by taurolithocholate. In contrast, simultaneous infusion of dehydrocholate prevented neither cholestasis nor development of the ultrastructural changes induced by taurolithocholate, which were more striking than those caused by taurolithocholate or 3beta-hydroxy-5-cholenoate alone. In addition, structural changes associated with cholestasis induced by these bile salts either singly or in combination were more pronounced and frequent in the periportal zone than elsewhere in the hepatic lobule. These results suggest that both taurolithocholate and 3beta-hydroxy-5-cholenoate induce cholestasis by affecting the structural and functional integrity of the bile canalicular membrane and also, in part, by forming untransportable precipitates. The contrasting effects of taurocholate and dehydrocholate on taurolithocholate-induced changes suggest that taurocholate overcomes the effect of taurolithocholate by solubilizing it into mixed micelles, but dehydrocholate and its metabolites have little or no such effect. The intralobular variation in severity of ultrastructural changes probably reflects the accumulation of bile salts in greater concentrations in hepatocytes near the portal triads.
通过静脉输注(每分钟每100克体重0.05至0.2微摩尔)牛磺石胆酸钠、3β-羟基-5-胆烯酸、牛磺胆酸钠和脱氢胆酸钠单独或联合给药,在大鼠中诱导胆汁淤积或胆汁分泌,给药前或给药后可选择是否结扎胆总管。监测胆汁流量,并通过扫描电子显微镜和透射电子显微镜检查胆汁盐给药后3小时内的超微结构变化。牛磺石胆酸钠诱导急性胆汁淤积和超微结构改变,主要包括胆小管扩张、微绒毛丢失和小管膜的板层转化。偶尔,小管腔内和肝细胞的小管周区域会出现结晶沉淀。3β-羟基-5-胆烯酸引起的超微结构变化与牛磺石胆酸钠诱导的相似,但程度较轻。脱氢胆酸的利胆作用比牛磺胆酸钠强,但两者均未引起明显的超微结构变化。当与牛磺石胆酸钠同时输注时,牛磺胆酸钠可逆转胆汁淤积,并在很大程度上阻止牛磺石胆酸钠诱导的超微结构变化的发生。相比之下,同时输注脱氢胆酸既不能阻止胆汁淤积,也不能阻止牛磺石胆酸钠诱导的超微结构变化的发生,这些变化比单独使用牛磺石胆酸钠或3β-羟基-5-胆烯酸引起的变化更明显。此外,这些胆汁盐单独或联合诱导的胆汁淤积相关的结构变化在门周区比肝小叶的其他部位更明显和频繁。这些结果表明,牛磺石胆酸钠和3β-羟基-5-胆烯酸通过影响胆小管膜的结构和功能完整性,部分地通过形成不可运输的沉淀物来诱导胆汁淤积。牛磺胆酸钠和脱氢胆酸对牛磺石胆酸钠诱导的变化的不同作用表明,牛磺胆酸钠通过将其溶解成混合微团来克服牛磺石胆酸钠的作用,但脱氢胆酸及其代谢产物几乎没有这种作用。超微结构变化严重程度的小叶内差异可能反映了门三联附近肝细胞中胆汁盐浓度的更高积累。